Progabide is primarily used in the treatment of epilepsy, particularly for managing seizures that are difficult to control with other antiepileptic medications. It works by modulating GABA receptors in the brain, enhancing inhibitory neurotransmission, which helps reduce the occurrence and severity of seizures. Additionally, Progabide has been explored for its potential therapeutic effects in neurological disorders such as Parkinson's disease and anxiety, due to its GABAergic activity. Its application in these areas is based on its ability to stabilize neuronal activity and provide neuroprotective benefits.